News

Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor…
Read More...

Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976)…
Read More...

Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions. The…
Read More...

Bosch Packaging Technology, a leading supplier of processing and packaging technology, expands its expertise in the non-aseptic packaging process for pharmaceuticals. Following the…
Read More...

The US Food and Drug Administration (FDA) has accepted for priority review Bristol-Myers Squibb's supplemental biologics license application (sBLA) for Opdivo (nivolumab) in previously…
Read More...

Virtus Pharmaceuticals has filed a lawsuit against the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS), seeking to prevent a monopoly, and…
Read More...

VBL Therapeutics has entered in to a long-term lease contract for a new stand-alone facility in Modiin, Israel. The site will house VBL's local biological drugs manufacturing facility,…
Read More...

IBM announced that many IBM U.S. employees fighting cancer will be able to tap into Watson for insights into their cancer treatment as well as potential clinical trial options. Through…
Read More...

Nexus BioPharma has signed an agreement to license TransChem's transition state chemistry technology for kinase inhibition. Kinases are enzymes that regulate essential cellular…
Read More...

Codexis has completed the second and final phase in the transfer of its CodeEvolver protein engineering platform technology to Merck, known as MSD outside the US and Canada, under a…
Read More...

Pilgrim Quality Solutions announced the validated release of Smart Solve Out Of Specification Management (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

Judge Claire C. Cecchi of the United States District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation against all three filers of…
Read More...

Bayer and DelSiTech Ltd., a Finnish drug delivery technology and drug development company, have signed a Collaboration and Technology Licence Agreement for the worldwide application of…
Read More...

Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharp & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development…
Read More...

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its…
Read More...

Merck, a leading science and technology company, announced an investment of more than € 50 million in a state-of-the-art packaging building at its pharmaceutical manufacturing site in…
Read More...

AstraZeneca has selected LLamasoft’s Supply Chain Guru and Data Guru as tools of choice for supply chain modelling. AstraZeneca is a global, innovation-driven biopharmaceutical…
Read More...

Pharma and biotech manufacturers benefit from best-in-class pharma MES combined with local implementation support from PAS-X Endorsed Service Partner. Werum IT Solutions, the…
Read More...

GlaxoSmithKline (GSK) has named Emma Walmsley as its new chief executive officer (CEO). Emma will succeed Andrew Witty as GSK CEO, when he retires on 31March 2017. Emma will join the…
Read More...

Ligand Pharmaceuticals has entered into a worldwide license agreement with Menlo Park, CA-based TeneoBio. Under the license, TeneoBio will be able to use the OmniFlic technology from…
Read More...